Literature DB >> 25725789

Accuracy of MRI for the diagnosis of metastatic cervical lymphadenopathy in patients with thyroid cancer.

Qinghua Chen1,2, Prashant Raghavan1, Sugoto Mukherjee1, Mark J Jameson3, James Patrie4, Wenjun Xin4, Junfang Xian2, Zhenchang Wang2, Paul A Levine3, Max Wintermark5,6.   

Abstract

PURPOSE: The aim of this study was to systematically compare a comprehensive array of magnetic resonance (MR) imaging features in terms of their sensitivity and specificity to diagnose cervical lymph node metastases in patients with thyroid cancer.
MATERIALS AND METHODS: The study included 41 patients with thyroid malignancy who underwent surgical excision of cervical lymph nodes and had preoperative MR imaging ≤4weeks prior to surgery. Three head and neck neuroradiologists independently evaluated all the MR images. Using the pathology results as reference, the sensitivity, specificity and interobserver agreement of each MR imaging characteristic were calculated.
RESULTS: On multivariate analysis, no single imaging feature was significantly correlated with metastasis. In general, imaging features demonstrated high specificity, but poor sensitivity and moderate interobserver agreement at best.
CONCLUSIONS: Commonly used MR imaging features have limited sensitivity at correctly identifying cervical lymph node metastases in patients with thyroid cancer. A negative neck MR scan should not dissuade a surgeon from performing a neck dissection in patients with thyroid carcinomas.

Entities:  

Keywords:  Accuracy; MRI; Metastatic lymph nodes; Neck dissection; Thyroid cancer

Mesh:

Year:  2015        PMID: 25725789     DOI: 10.1007/s11547-014-0474-0

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  20 in total

Review 1.  Detection of metastasis in cervical lymph nodes: CT and MR criteria and differential diagnosis.

Authors:  P M Som
Journal:  AJR Am J Roentgenol       Date:  1992-05       Impact factor: 3.959

Review 2.  Modern imaging lymph node staging of the head and neck region.

Authors:  C Krestan; A M Herneth; M Formanek; C Czerny
Journal:  Eur J Radiol       Date:  2006-05-09       Impact factor: 3.528

Review 3.  Imaging surveillance of differentiated thyroid cancer.

Authors:  Nathan A Johnson; Shane O LeBeau; Mitchell E Tublin
Journal:  Radiol Clin North Am       Date:  2011-05       Impact factor: 2.303

4.  Optimal size criteria of malignant lymph nodes in the treatment planning of radiotherapy for esophageal cancer: evaluation by computed tomography and magnetic resonance imaging.

Authors:  T Mizowaki; Y Nishimura; Y Shimada; Y Nakano; M Imamura; J Konishi; M Hiraoka
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-12-01       Impact factor: 7.038

5.  Computed tomography in evaluating metastatic neck disease.

Authors:  M H Stevens; R Harnsberger
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1988-09

Review 6.  Lymph nodes of the neck.

Authors:  P M Som
Journal:  Radiology       Date:  1987-12       Impact factor: 11.105

7.  Metastatic neck disease. Evaluation by computed tomography.

Authors:  M Friedman; V K Shelton; M Mafee; P Bellity; V Grybauskas; E Skolnik
Journal:  Arch Otolaryngol       Date:  1984-07

8.  Metastatic neck disease. A clinical/radiographic/pathologic correlative study.

Authors:  R Feinmesser; J L Freeman; A M Noyek; B D Birt
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1987-12

9.  Performance of preoperative sonographic staging of papillary thyroid carcinoma based on the sixth edition of the AJCC/UICC TNM classification system.

Authors:  Jeong Seon Park; Kyu-Ri Son; Dong Gyu Na; Eunhee Kim; Sungjun Kim
Journal:  AJR Am J Roentgenol       Date:  2009-01       Impact factor: 3.959

10.  Computed tomographic evaluation of regional lymph node involvement in cancer of the oral cavity and oropharynx.

Authors:  L G Close; M Merkel; M F Vuitch; J Reisch; S D Schaefer
Journal:  Head Neck       Date:  1989 Jul-Aug       Impact factor: 3.147

View more
  8 in total

1.  Evaluation of (124)I PET/CT and (124)I PET/MRI in the management of patients with differentiated thyroid cancer.

Authors:  Laurent Dercle; Désirée Deandreis; Marie Terroir; Sophie Leboulleux; Jean Lumbroso; Martin Schlumberger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-06       Impact factor: 9.236

2.  Predictive values of serum VEGF and CRP levels combined with contrast enhanced MRI in hepatocellular carcinoma patients after TACE.

Authors:  Zhi Li; Tong-Qing Xue; Xiao-Yu Chen
Journal:  Am J Cancer Res       Date:  2016-10-01       Impact factor: 6.166

3.  Imaging with (124)I in differentiated thyroid carcinoma: is PET/MRI superior to PET/CT?

Authors:  I Binse; T D Poeppel; M Ruhlmann; B Gomez; L Umutlu; A Bockisch; S J Rosenbaum-Krumme
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-12-19       Impact factor: 9.236

4.  Radiomics Profiling Identifies the Value of CT Features for the Preoperative Evaluation of Lymph Node Metastasis in Papillary Thyroid Carcinoma.

Authors:  Guoqiang Yang; Fan Yang; Fengyan Zhang; Xiaochun Wang; Yan Tan; Ying Qiao; Hui Zhang
Journal:  Diagnostics (Basel)       Date:  2022-04-29

5.  Magnetic resonance imaging (MRI) radiomics of papillary thyroid cancer (PTC): a comparison of predictive performance of multiple classifiers modeling to identify cervical lymph node metastases before surgery.

Authors:  Hui Qin; Qiao Que; Peng Lin; Xin Li; Xin-Rong Wang; Yun He; Jun-Qiang Chen; Hong Yang
Journal:  Radiol Med       Date:  2021-07-08       Impact factor: 3.469

6.  Impact of combined FDG-PET/CT and MRI on the detection of local recurrence and nodal metastases in thyroid cancer.

Authors:  Johann-Martin Hempel; Roman Kloeckner; Sandra Krick; Daniel Pinto Dos Santos; Simin Schadmand-Fischer; Patrick Boeßert; Sotirios Bisdas; Matthias M Weber; Christian Fottner; Thomas J Musholt; Mathias Schreckenberger; Matthias Miederer
Journal:  Cancer Imaging       Date:  2016-11-03       Impact factor: 3.909

7.  Using Diffusion-Weighted MRI to Predict Central Lymph Node Metastasis in Papillary Thyroid Carcinoma: A Feasibility Study.

Authors:  Heng Zhang; Shudong Hu; Xian Wang; Wenhua Liu; Junlin He; Zongqiong Sun; Yuxi Ge; Weiqiang Dou
Journal:  Front Endocrinol (Lausanne)       Date:  2020-06-12       Impact factor: 5.555

Review 8.  Magnetic Fields and Cancer: Epidemiology, Cellular Biology, and Theranostics.

Authors:  Massimo E Maffei
Journal:  Int J Mol Sci       Date:  2022-01-25       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.